Understanding COVID-19 vaccine efficacy.

Lipsitch, Marc; Dean, Natalie E

Lipsitch, Marc; Dean, Natalie E.

Lipsitch M; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. mlipsitc@hsph.harvard.edu nataliedean@ufl.edu.
Dean NE; Department of Biostatistics, University of Florida, Gainesville, FL 32611, USA. mlipsitc@hsph.harvard.edu nataliedean@ufl.edu.

Science ; 370(6518): 763-765, 2020 11 13.

Article in English | MEDLINE | ID: covidwho-1004088

Subject(s)

Betacoronavirus/immunology; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Viral Vaccines/immunology; Age Factors; Betacoronavirus/physiology; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Clinical Laboratory Techniques; Clinical Trials, Phase III as Topic; Coronavirus Infections/diagnosis; Coronavirus Infections/immunology; Coronavirus Infections/transmission; Coronavirus Infections/virology; Humans; Observational Studies as Topic; Pneumonia, Viral/immunology; Pneumonia, Viral/transmission; Pneumonia, Viral/virology; Randomized Controlled Trials as Topic; SARS-CoV-2; Vaccination; Viral Load; Viral Vaccines/administration & dosage; Viral Vaccines/adverse effects; Virus Shedding

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Science Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google